Form 4: Cardlytics CEO Sells Shares for Tax Obligations

Cardlytics CEO Amit Gupta sold 5,807 shares of common stock at a weighted average price of $1.17 to cover tax withholding obligations from RSU vesting.

Summary

• Cardlytics CEO Amit Gupta acquired 14,349 shares of common stock on January 1, 2026, upon the vesting of restricted stock units (RSUs).
• On January 5, 2026, Mr. Gupta sold 5,807 shares of common stock at a weighted average price of $1.17 per share.
• The sale was exclusively to satisfy tax withholding obligations related to the RSU vesting and not for any other purpose.
• The shares were sold in multiple transactions at prices ranging from $1.12 to $1.235, inclusive.
• Following these transactions, Mr. Gupta beneficially owns 506,852 shares of common stock.
• The original RSU award was for 114,796 shares, vesting in eight equal installments, with the final installment due on April 1, 2026.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary sale to cover tax obligations from RSU vesting, which is a neutral event for the company's fundamentals or future prospects.

Positives

• The RSU vesting indicates continued compensation and retention of the CEO.
• The sale was solely for tax obligations, not a discretionary sale, which is a standard practice for equity compensation.

Negatives

• The sale of 5,807 shares reduces the CEO's direct beneficial ownership, although this is a routine tax-related transaction.
• The sale price of $1.17 is relatively low, which might reflect the current market valuation of the company's stock.

Future Outlook

The filing indicates that the remaining portion of the RSU award, approximately 14,350 shares, is scheduled to vest on April 1, 2026, contingent on the CEO's continued employment.

Industry Context

This transaction is a routine insider filing common across publicly traded companies where executives receive equity compensation that vests over time, often requiring a portion of shares to be sold to cover tax liabilities upon vesting.

Comparison to Industry Standards

• The practice of selling shares to cover tax withholding obligations upon RSU vesting is a standard industry practice for executive equity compensation across all sectors. There are no specific comparable companies or projects mentioned in this filing to assess against.

Stakeholder Impact

• Shareholders: The sale is a minor reduction in insider ownership but is a standard practice for tax purposes, unlikely to significantly impact shareholder confidence.
• Employees: The vesting of RSUs and subsequent tax-related sale is a common aspect of executive compensation, reflecting standard practices.

Next Steps

• The final installment of the RSU award (approximately 14,350 shares) is scheduled to vest on April 1, 2026.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by the CEO to cover tax obligations arising from RSU vesting. Such transactions are common and generally do not reflect a change in management's outlook or a strategic move. Therefore, it provides no new fundamental information to alter an existing investment thesis, warranting a 'hold' recommendation based solely on this filing.

Keywords

Cardlytics, CDLX, Amit Gupta, SEC Form 4, Insider Trading, Stock Sale, RSU Vesting, Executive Compensation, Tax Withholding